MILESTONE PHARMACEUTICALS IN (MIST) Stock Balance Sheet
NASDAQ:MIST - Nasdaq - CA59935V1076 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 45.09M | 25.31M | 13.76M | 7.60M | 114.10M | |||
| Marketable Securities | 10.87M | 44.38M | 52.24M | 56.90M | 0.00 | |||
| Receivables | 2.16M | 2.39M | 3.85M | 1.20M | 500.00K | |||
| Other Current Assets | 2.36M | 1.84M | 3.18M | 6.00M | 4.30M | |||
| Total Current Assets | 60.48M | 73.93M | 73.03M | 71.80M | 118.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.41M | 1.57M | 2.19M | 2.70M | 900.00K | |||
| Total Non-Current Assets | 1.41M | 1.57M | 2.19M | 2.70M | 900.00K | |||
| TOTAL ASSETS | 61.88M | 75.50M | 75.23M | 74.50M | 119.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 10.58M | 6.19M | 3.25M | 3.90M | 2.40M | |||
| Accounts Payable | 2.38M | 1.93M | 3.98M | 2.30M | 4.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 12.96M | 8.13M | 7.23M | 6.10M | 6.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 54.29M | 53.35M | 49.77M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 758.00K | 874.00K | 1.46M | 2.00M | 500.00K | |||
| Total Non-Current Liabilities | 55.05M | 54.23M | 51.23M | 2.00M | 400.00K | |||
| TOTAL LIABILITIES | 68.01M | 62.35M | 58.45M | 8.10M | 7.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -335.23M | -314.47M | -277.57M | -232.00M | -153.40M | |||
| Additional Paid In Capital | 40.92M | 39.57M | 33.83M | 24.40M | 15.70M | |||
| Common Shares | 288.19M | 288.05M | 260.50M | 273.90M | 251.90M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | -1.60M | |||
| Shares Outstanding | 53.46M | 53.35M | 33.48M | 34.30M | 29.90M | |||
| Tangible Book Value per Share | -0.11 | 0.25 | 0.50 | 1.93 | 3.77 | |||
| Total Shareholders' Equity | -6.12M | 13.15M | 16.77M | 66.30M | 112.60M | |||
| TOTAL LIABILITIES AND EQUITY | 61.88M | 75.50M | 75.23M | 74.50M | 119.80M | |||
| Statistics | ||||||||
| Debt/Equity | -8.87 | 4.06 | 2.97 | N/A | N/A | |||
| Current Ratio | 4.67 | 9.10 | 10.11 | 11.77 | 17.49 | |||
| Return On Assets (ROA) | -83.91% | -54.99% | -79.34% | -78.38% | -35.77% | |||
| Return On Equity (ROE) | N/A | -315.81% | -355.88% | -88.07% | -38.06% | |||
All data in USD , ROIC based on taxRate of 0.21